Study Design. Retrospective case series from a multicenter database.
Growing rod constructs have become increasingly popular for the treatment of early-onset spinal deformity. Unlike traditional methods for the treatment of certain spinal deformities in young children which have been directed at early spinal arthrodesis, growing rods aim to limit fusion segments, control spinal deformity, and promote growth of the spine.
1,2 To achieve this growth, patients with growing rod devices typically undergo multiple surgical lengthening and often device exchanges up to the age of skeletal maturity.
Although the risk of neurologic injury and the importance of intraoperative neuromonitoring have been well described in spinal fusion for spinal deformity. [3] [4] [5] We are not aware of previous studies of neurologic risk in growing rod spine instrumentation. The incidence of neurologic events during primary growing rod surgeries, implant exchanges, and implant lengthenings is therefore unknown. The purpose of this study was to evaluate the risk of neurologic injury during growing rod surgeries and to determine whether intraoperative neuromonitoring is necessary for all growing rod procedures.
Materials and Methods
The multicenter database of the Growing Spine Study Group was reviewed to determine the number of primary growing rod surgeries, implant exchanges, and device lengthenings that were performed between 1987 and 2007 as well as the number of neuromonitoring changes and neurologic injuries reported over the same time period. VEPTR devices and any other constructs with rib attachments were excluded from the study. For all cases with reported neuromonitoring changes or neurologic injuries, additional information was extracted from the database and chart review including demographic data, patient diagnosis, severity of spinal deformity, nature of the neurologic event, and clinical outcome.
To be sure that no neurologic events were missed, a questionnaire was sent to all contributing surgeons requesting detailed 
Results
Between 1987 and 2007, 782 growing rod surgeries were performed on 252 patients by 20 surgeons from 14 centers. These cases included 252 primary growing rod implantations, 168 implant exchanges, and 362 lengthenings. Based on surgeon surveys, 231 of 252 (92%) primary surgeries, 116 of 168 (69%) implant exchanges, and 222 of 362 (61%) lengthenings were performed with neuromonitoring. In the majority of cases, both transcranial motor-evoked potentials (TceMEPs) and somatosensory-evoked potentials (SSEPs) were used ( Table 1) .
We identified 2 cases of neuromonitoring changes among primary growing rod implantations that were monitored (0.9%, 2/231) and no cases of neurologic injury after primary surgery (0%, 0/252) ( Table 2 ). The first case involved a 5-year-old girl with neurofibromatosis and intracanal neurofibromas. Preoperative radiographs demonstrated a 50°right thoracic scoliosis and 102°thoracic kyphosis. Intraoperatively, after instrumentation and correction, the child lost all signals (only SSEPs were used). The child failed a subsequent wake up test, and the surgeon reduced the amount of correction. SSEPs returned to baseline, and the patient awoke without a clinical deficit. The second case involved a 3-year-old girl with CHARGE syndrome and a 74°left thoracic scoliosis with no significant kyphosis. After instrumentation and correction the patient experienced a decrease in TceMEPs. Intraoperative correction was reduced, the mean arterial pressure was increased, and the motor signals returned to baseline. The patient did not have a postoperative clinical deficit.
There was one intraoperative neuromonitoring change among those implant exchanges, which were monitored (0.9%, 1/116). This case resulted in the only reported clinical injury in our series (0.6%, 1/168). The event occurred in a 10-year-old child with infantile idiopathic scoliosis. Radiographs demonstrated 55°of left thoracic scoliosis and 42°of thoracic kyphosis. The child had previously had a single growing rod construct placed without incident. During follow-up, 2 hooks pulled out at the top of the construct, necessitating implant exchange. Intraoperatively, a large fusion mass was present at the site of the previous hooks. During attempted pedicle screw placement through the fusion mass at the upper thoracic vertebrae, lower extremity SSEP amplitudes decreased significantly. A wake up test was performed, which demonstrated intact lower extremity function bilaterally. Screw placement was abandoned, and hooks were placed in the fusion mass. After surgery, the child had a foot drop in the left lower extremity. Two weeks after surgery, ankle dorsiflexion had improved to 4 of 5 motor strength. Three months after surgery, the patient had recovered completely (Table 3) .
Only one neuromonitoring event occurred among those device lengthenings that were monitored (0.5%, 1/222), and no clinical injuries were reported due to lengthenings (0%, 0/362). This one neuromonitoring change (only SSEPs were used) occurred in the same 5-year-old girl with neurofibromatosis and intracanal tumors who had had an event during her primary surgery. Intraoperatively, the lengthening was reduced and the child did not develop a clinical deficit.
A summary of all the neurologic changes (both monitoring and clinical) in our series is listed in Table 3 .
Discussion
Although growing rods are becoming more popular for the treatment of severe spinal deformity in patients with earlyonset scoliosis, little data exist regarding the neurologic risk associated with these surgeries. This study represents the largest reported series of growing rod procedures, and our data demonstrate that the risk of a clinical neurologic injury resulting from growing rod surgery is low. There were no permanent neurologic injuries in 782 growing rod surgeries, with a 0.1% rate of temporary neurologic injury. This single clinical injury occurred from attempted pedicle screw placement during implant exchange and the deficit resolved within 3 months. Neuromonitoring changes occurred during 0.9% of primary implant surgeries, 0.9% of implant exchanges, and 0.5% of lengthenings.
Based on our study, the rate of neuromonitoring changes during primary growing rod implantation (2/ 231, 0.9%) and exchange (1/116, 0.9%) justifies the use of intraoperative neuromonitoring during these surgeries. The single neuromonitoring change that occurred during a lengthening was in a child with an intracanal tumor who also had a monitoring change during the primary surgery. As there were no neurologic events (monitoring or injury) in all 361 lengthenings in patients with no previous events, intraoperative neuromonitoring may not be necessary in these cases.
Avoidance of unnecessary monitoring has its advantages. At the primary authors' institution, the hospital charge for neuromonitoring a lengthening is approximately $800 per case. As growing spine patients require frequent lengthenings until skeletal maturity (often once every 6 months), the overall cost of monitoring these patients is significant. In addition, the use of both TceMEPs and SSEPS usually requires total intravenous anesthesia, which can result in less reliable amnestic properties and potentially slower wake up times compared with inhaled anesthetics. 6 Lengthenings can usually be performed within 30 minutes from "skin to skin," which is comparable with the time it takes to perform a Stagnara wake up test. As a result, neuromonitoring may not be required for lengthenings in those patients who did not have an event during the primary implantation. However, this study may lack sufficient numbers to state this definitively.
A limitation of this study is that primary neuromonitoring data (i.e., TceMEP and SSEP tracings, amplitude, etc.) were not prospectively collected as part of the Growing Spine Study Group database. We therefore, relied on surgeon reporting to determine the presence of neuromonitoring changes. As a result, we are unable to comment on the number of presumably minor alerts that could have been related to changes in blood pressure or body temperature. Similarly, we do not have more detailed data on what thresholds constituted a legitimate neuromonitoring change (such as % change in amplitude) for each surgery at each institution.
At the time of presentation of this study at the 2008 Annual Meeting of the Pediatric Orthopedic Society of North America, we became aware of 4 anecdotal cases (outside of the Growing Spine Study Group) of neuromonitoring changes during lengthenings in children with uneventful primary surgeries. As these events can be catastrophic but rare, we believe a brief discussion of a few of these cases is warranted. One case occurred in a 5-year-old girl with Prader-Willi syndrome. Despite an uneventful primary implantation, the child lost TceMEPs and had a 50% reduction in SSEPs during distraction at 2 separate attempted lengthenings. Both times the monitoring signals normalized after the distraction was removed, and the child was eventually able to be distracted slowly without a monitoring change. No clinical injuries resulted. Another case occurred in an 8-year-old girl with scoliosis and lateral gaze palsy. Although the patient had undergone primary surgery and 2 subsequent lengthenings without monitoring changes, TceMEPS were lost while being distracted during her third lengthening. Signals returned to baseline after the distraction was removed, and the child awoke without a neurologic deficit. One child with telosteogenesis, who originally had an uneventful primary surgery and first lengthening procedure, developed neuromonitoring changes when being flipped prone for her second lengthening (before distraction). Signals normalized when the child was returned to the supine position, and she eventually was lengthened safely in the lateral decubitus position.
Such anecdotal reports are of limited value because we do not know the denominator of these cases, and it is therefore impossible to know the incidence of these events. However, when examining the occurrence rates of rare yet catastrophic events, such anecdotal cases should not be ignored.
Conclusion
In this study, the largest reported series of growing rod surgeries, the incidence of clinical neurologic injury was extremely low, with a 0.1% rate of temporary neurologic injury. The rate of neuromonitoring changes during primary growing rod implantation and exchange justifies the use of intraoperative neuromonitoring for these surgeries. As there were no neurologic events in all 361 lengthenings in patients with no previous events, the need for intraoperative neuromonitoring may be questioned, though the sample size is not sufficient to make definitive recommendations.
Key Points
• Based on the largest reported series of growing rod surgeries, the incidence of neuromonitoring changes during primary surgeries (0.9%), implant exchanges (0.9%), and lengthenings (0.5%) is rare.
• The single neuromonitoring change that occurred during a lengthening was in a child with an intracanal tumor who also had a change during the primary surgery.
• The use of intraoperative neuromonitoring seems justified for primary surgeries and implant exchanges. 
